ArticleJournal of anesthesia2025
A new acute pain service fee addition in Japan: a nationwide study based on a reimbursement claims database.
Article in Journal of anesthesia, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Implementation and early outcomes of a multidisciplinary acute pain service following the 2022 Japanese reimbursement revision.Journal of anesthesia · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposePostoperative pain management is critical for psychological and physical patient outcomes. In April 2022, the Japanese government introduced a new Acute Pain Service (APS) fee addition into the health care reimbursement system to promote structured APS implementation. This study aims to describe the current status of APS addition and explore its association with patient and hospital outcomes.
methodsWe conducted a retrospective study using a nationwide claims database. Patients who underwent surgery with general anesthesia from April 2022 to June 2023 were included. Surgical procedures were categorized into 15 departments or classified as "mixed," and APS addition claim frequency was summarized. Propensity score matching and multivariable regression analyses were performed.
resultsA total of 14,022 patients with APS addition and 551,315 without were included. The relative frequency of APS addition was 2.48%, with the highest in esophageal surgery (11.8%). APS addition claims gradually increased over time. Propensity score matching showed no apparent differences in total hospitalization costs or length of stay between groups. However, significant interactions were observed between APS addition and patient age. Among 90-year-old patients, the estimated mean cost reduction [95% confidence interval (CI)] was 4.6% [2.1%, 7.0%] for males and 4.7% [2.4%, 6.9%] for females, while the estimated mean [95% CI] reduction in length of stay was 6.7% [3.0%, 10.3%] and 8.9% [5.6%, 12.1%], respectively.
conclusionAlthough the overall effects of APS addition were minimal, age-stratified analyses suggest that it may be associated with improved outcomes among older patients. These exploratory findings warrant further investigation.
Indexed as
Identifiers
40481974What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.